University of Arizona-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Arizona - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013638
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for educational resources in culture, center for applied sociology, language and literacy, academic affairs, college of engineering, college of medicine, accounting, and agricultural and biosystems engineering. It also provides health services and medical center for students and employees. UA offers educational services in the areas of space sciences, optics, biosciences, arts and humanities, business, technology transfer, and others. The university includes College of Fine Arts, College of Humanities, College of Optical Sciences, College of Science and Eller College of Management is operated under the University of Arizona. UA is headquartered in Tucson, Arizona, the US.

University of Arizona – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Arizona, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Arizona, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Arizona, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Arizona, Medical Devices Deals, 2011 to YTD 2017 9
University of Arizona, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Arizona, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
21st Century Oncology Enters into Research Agreement with The University of Arizona 11
PierianDx and Phoenix Children’s Hospital Enter into Co-Development Agreement with University of Arizona 12
St. Joseph’s Hospital Enters Into Joint Venture Agreement With University Of Arizona College Of Medicine 13
Licensing Agreements 14
Akhu Therapeutics Enters into Licensing Agreement with University of Arizona 14
Teleost Enters Into Licensing Agreement with University of Arizona 15
Botanisol Enters Into Licensing Agreement with University of Arizona 16
University of Arizona – Key Competitors 17
University of Arizona – Key Employees 18
University of Arizona – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Government and Public Interest 21
Nov 14, 2017: $8.5 million grant awarded to improve asthma care with the Navajo nation 21
Nov 14, 2017: $8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation 22
Sep 27, 2017: Researchers Receive DOD Grant to Study Link Between Traumatic Brain Injury and Dementia 23
Jul 17, 2017: Top Cancer Research Facilities Nationwide Fueled With $1.2 Million In New Slate Of Grants 25
Dec 13, 2016: Cholesterol-fighting drugs lower risk of Alzheimer’s disease 26
Dec 01, 2016: UA receives $1.5 million to study cancer in firefighters 28
Feb 25, 2016: The Lipedema Foundation: $2.2M Awarded to Study Bad Fat 29
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
University of Arizona, Pharmaceuticals & Healthcare, Key Facts 2
University of Arizona, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Arizona, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Arizona, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Arizona, Deals By Therapy Area, 2011 to YTD 2017 8
University of Arizona, Medical Devices Deals, 2011 to YTD 2017 9
University of Arizona, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
21st Century Oncology Enters into Research Agreement with The University of Arizona 11
PierianDx and Phoenix Children's Hospital Enter into Co-Development Agreement with University of Arizona 12
St. Joseph's Hospital Enters Into Joint Venture Agreement With University Of Arizona College Of Medicine 13
Akhu Therapeutics Enters into Licensing Agreement with University of Arizona 14
Teleost Enters Into Licensing Agreement with University of Arizona 15
Botanisol Enters Into Licensing Agreement with University of Arizona 16
University of Arizona, Key Competitors 17
University of Arizona, Key Employees 18
University of Arizona, Other Locations 19
University of Arizona, Subsidiaries 20

★海外企業調査レポート[University of Arizona-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apexigen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of cancer. The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell responses. It also …
  • Allianz Seguros SA:企業の戦略・SWOT・財務分析
    Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FirstEnergy Corp (FE):電力:M&Aディール及び事業提携情報
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …
  • London and Quadrant Housing Trust:企業の戦略・SWOT・財務情報
    London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report Summary London and Quadrant Housing Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Nationwide Children's Hospital (Nationwide Children's) is a provider of pediatric health care and research services. The hospital offers pediatric services in the areas of gastroenterology, hematology and nutrition, heart care, left lip and palate, oncology ad bone marrow transplantation. It …
  • Gould Paper Corporation, Inc.:企業の戦略・SWOT・財務情報
    Gould Paper Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gould Paper Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Wentworth Resources Ltd (WRL)-石油・ガス分野:企業M&A・提携分析
    Summary Wentworth Resources Limited (Wentworth) is an independent upstream oil and gas company. It conducts the exploration and development of oil and natural gas reserves. The company has producing gas assets in Tanzania, oil and gas exploration activities in both Mozambique and Tanzania. The compa …
  • Intermountain Healthcare Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Infratil Ltd (IFT):企業の財務・戦略的SWOT分析
    Infratil Ltd (IFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Evercore Inc:企業のM&A・事業提携・投資動向
    Evercore Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evercore Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • Kajima Corp (1812):企業の財務・戦略的SWOT分析
    Kajima Corp (1812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Moog Inc.:企業のM&A・事業提携・投資動向
    Moog Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moog Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Credit Agricole CIB S.A.:企業の戦略的SWOT分析
    Credit Agricole CIB S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Saudi Electricity Co (5110):電力:M&Aディール及び事業提携情報
    Summary Saudi Electricity Co (SEC) is an energy utility. Through its subsidiaries, the company generates, transmits and distributes electricity; and carries out operations of the fiber optic networks, trading, realization of renewable energy, and other. It produces electricity in gas, combined, stea …
  • 84 Lumber Company:企業の戦略・SWOT・財務分析
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Eurasian Natural Resources Corporation Ltd:企業のM&A・事業提携・投資動向
    Eurasian Natural Resources Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurasian Natural Resources Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆